Search - tctmd.com

Displaying 101 - 109 of 109

Sort: Relevancy | Date

Presentation TCT 2013

Feasibility of noninvasive atherectomy: plaque ablation with cavitation-based focused ultrasound (histotripsy)

Presenter: Adam Maxwell, Zhen Xu, Hitinder Gurm

January 31, 2013

Presentation TCT 2012

Regulatory Requirements for DCB Development and Approval in the United States

Presenter: Kenneth Cavanaugh Jr

October 25, 2012

Presentation TCT 2012

The Deep Vein Thrombosis Problem: How Strong Is the CAVENT Study Evidence?

Presenter: Anthony Comerota

October 24, 2012

Presentation TCT 2012

Pragmatic Pre- and Post-Market Global Harmonization: Lessons from Japan and the United States

Presenter: Kenneth Cavanaugh Jr

October 24, 2012

Presentation TCT 2012

CLI and Device Intervention Across the Pacific: An FDA View

Presenter: Kenneth Cavanaugh Jr

October 24, 2012

Presentation TCT 2012

Case 2: Management of Clotted Inferior Vena Cava Filter

Presenter: Mahmood Razavi

October 24, 2012

Presentation TCT 2012

TCT-114: Feasibility of Noninvasive Atherectomy: Plaque Ablation with Cavitation-Based Focused Ultrasound (Histotripsy)

Presenter: Adam Maxwell

October 22, 2012

Presentation TCT 2012

Case Selection Caveats from the U.S. CoreValve Pivotal Clinical Trial

Presenter: Jeffrey Popma

October 22, 2012

News Conference News

Complications After TAVR: Manageable, But Important to Consider

November 09, 2011

Advertisement

Feasibility of noninvasive atherectomy: plaque ablation with cavitation-based focused ultrasound (histotripsy)

Regulatory Requirements for DCB Development and Approval in the United States

The Deep Vein Thrombosis Problem: How Strong Is the CAVENT Study Evidence?

Pragmatic Pre- and Post-Market Global Harmonization: Lessons from Japan and the United States

CLI and Device Intervention Across the Pacific: An FDA View

Case 2: Management of Clotted Inferior Vena Cava Filter

TCT-114: Feasibility of Noninvasive Atherectomy: Plaque Ablation with Cavitation-Based Focused Ultrasound (Histotripsy)

Case Selection Caveats from the U.S. CoreValve Pivotal Clinical Trial

Complications After TAVR: Manageable, But Important to Consider

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content